Humberto Gutiérrez

Dr. Humberto Gutiérrez


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Trends in Neurosciences
Verified
Journal Article
Open access
HGHumberto Gutiérrez
Humberto Gutiérrez
ADAlun M. Davies
Alun M. Davies
The nuclear factor-kappa B (NF-κB) family of transcription factors has recently emerged as a major regulator of the growth and elaboration of neural processes. NF-κB signaling has been implicated in controlling axon initiation, elongation, guidance and branching and in regulating dendrite arbor size and complexity during development and dendritic spine density in the adult. NF-κB is activated by a variety of extracellular signals, and either promotes or inhibits growth depending on the phosphorylation status of the p65 NF-κB subunit. These novel roles for NF-κB, together with recent evidence implicating NF-κB in the regulation of neurogenesis in the embryo and adult, have important implications for neural development and for learning and memory in the mature nervous system.

1 April 2005 in Development
Verified
Journal Article
Open access
PDF file
HGHumberto Gutiérrez
Humberto Gutiérrez
VHValerie A. Hale
Valerie A. Hale
XDXavier Dolcet
Xavier Dolcet
ADAlun Davies
Alun Davies
The proper growth and elaboration of neural processes is essential for the establishment of a functional nervous system during development and is an integral feature of neural plasticity throughout life. Nuclear factor-kappa B(NF-κB) is classically known for its ubiquitous roles in inflammation,immune and stress-related responses and regulation of cell survival in all tissues, including the nervous system. NF-κB participation in other cellular processes remains poorly understood. Here we report a mechanism for controlling the growth of neural processes in developing peripheral and central neurons involving the transcription factor NF-κB. Inhibiting NF-κB activation with super-repressor IκB-α, BAY 11 7082(IκB-α phosphorylation inhibitor) or N-acetyl-Leu-Leu-norleucinal(proteosomal degradation inhibitor), or inhibiting NF-κB transcriptional activity with κB decoy DNA substantially reduced the size and complexity of the neurite arbors of sensory neurons cultured with brain-derived neurotrophic factor while having no effect on their survival. NF-κB exerted this effect during a restricted period of development following the phase of naturally occurring neuronal death when the processes and connections of the remaining neurons are extensively modified and refined. Inhibiting NF-κB activation or NF-κB transcriptional activity in layer 2 pyramidal neurons in postnatal somatosensory cortical slices reduced dendritic arbor size and complexity. This function of NF-κB has important implications for neural development and may provide an explanation for reported involvement of NF-κB in learning and memory.

12 March 2014 in Epigenetics
Verified
Journal Article
Closed access
KTKatie L Togher
Katie L Togher
MOMajella O'Keeffe
Majella O'Keeffe
AKAli S Khashan
Ali S Khashan
HGHumberto Gutiérrez
Humberto Gutiérrez
LKLouise C Kenny
Louise C Kenny
GOGerard W. O'Keeffe
Gerard W. O'Keeffe
“Fetal programming” is a term used to describe how early-life experience influences fetal development and later disease risk. In humans, prenatal stress-induced fetal programming is associated with increased risk of preterm birth, and a heightened risk of metabolic and neurological diseases later in life. A critical determinant of this is the regulation of fetal exposure to glucocorticoids by the placenta. Glucocorticoids are the mediators through which maternal stress influences fetal development. Excessive fetal glucocorticoid exposure during pregnancy results in low birth weight and abnormalities in a number of tissues. The amount of fetal exposure to maternal glucocorticoids depends on the expression of HSD11B2, an enzyme predominantly produced by the syncytiotrophoblast in the placenta. This protects the fetus by converting active glucocorticoids into inactive forms. In this review we examine recent findings regarding placental HSD11B2 that suggest that its epigenetic regulation may mechanistically l...

27 January 2008 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
TVThomas N Vizard
Thomas N Vizard
GOGerard W. O'Keeffe
Gerard W. O'Keeffe
HGHumberto Gutiérrez
Humberto Gutiérrez
CKClaudine H Kos
Claudine H Kos
DRDaniela Riccardi
Daniela Riccardi
ADAlun M Davies
Alun M Davies

6 January 2008 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
GOGerard W. O'Keeffe
Gerard W. O'Keeffe
HGHumberto Gutiérrez
Humberto Gutiérrez
PPPier Paolo Pandolfi
Pier Paolo Pandolfi
Carlo RiccardiCarlo Riccardi
Carlo Riccardi
ADAlun M Davies
Alun M Davies

1 August 2004 in Development
Verified
Journal Article
Open access
PDF file
HGHumberto Gutiérrez
Humberto Gutiérrez
XDXavier Dolcet
Xavier Dolcet
MTMary Tolcos
Mary Tolcos
ADAlun Davies
Alun Davies
Although hepatocyte growth factor (HGF) and its receptor tyrosine kinase MET are widely expressed in the developing and mature central nervous system,little is known about the role of MET signaling in the brain. We have used particle-mediated gene transfer in cortical organotypic slice cultures established from early postnatal mice to study the effects of HGF on the development of dendritic arbors of pyramidal neurons. Compared with untreated control cultures, exogenous HGF promoted a highly significant increase in dendritic growth and branching of layer 2 pyramidal neurons, whereas inactivation of endogenous HGF with function-blocking, anti-HGF antibody caused a marked reduction in size and complexity of the dendritic arbors of these neurons. Furthermore, pyramidal neurons transfected with an MET dominant-negative mutant receptor likewise had much smaller and less complex dendritic arbors than did control transfected neurons. Our results indicate that HGF plays a role in regulating dendritic morphology in the developing cerebral cortex.